Back to search

Article

Endogenous/Exogenous Nanovaccines Synergistically Enhance Dendritic Cell-mediated Tumor Immunotherapy

2022-11-08

Abstract excerpt

Traditional dendritic cell (DC)-mediated immunotherapy is usually suppressed by weak immunogenicity in tumors and generally leads to unsatisfactory outcomes. Synergistic exogenous/endogenous immunogenic activation can provide an alternative strategy for evoking a robust immune response by promoting DC activation. Herein, we prepared Ti 3 C 2 MXene-based nanoplatforms (termed MXP) with high-efficiency near-infrared...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
620a57ca-aa23-5063-97e6-8fd2ca9587e6
DOI
10.21203/rs.3.rs-2021481/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Endogenous/Exogenous Nanovaccines Synergistically Enhance Dendritic Cell-mediated Tumor ImmunotherapyDOI 10.21203/rs.3.rs-2021481/v1
Select a neighboring publication to make it the new centre.